{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:25:26Z","timestamp":1790162726733,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012949","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000}}],"reference-count":93,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012949.pub2","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T23:58:42Z","timestamp":1579651122000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Probiotics for people with cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Michael J","family":"Coffey","sequence":"first","affiliation":[{"name":"University of New South Wales; School of Women's and Children's Health; Level 8, Centre for Child Health Research & Innovation Bright Alliance Building Cnr Avoca & High Streets Randwick Sydney NSW Australia 2031"},{"name":"Sydney Children's Hospital; Junior Medical Officers Department; High Street Randwick Sydney NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Garg","sequence":"additional","affiliation":[{"name":"University of New South Wales; School of Women's and Children's Health; Level 8, Centre for Child Health Research & Innovation Bright Alliance Building Cnr Avoca & High Streets Randwick Sydney NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Homaira","sequence":"additional","affiliation":[{"name":"University of New South Wales; School of Women's and Children's Health; Level 8, Centre for Child Health Research & Innovation Bright Alliance Building Cnr Avoca & High Streets Randwick Sydney NSW Australia 2031"},{"name":"Sydney Children's Hospital; Respiratory Department; High Street Randwick Sydney New South Wales Australia NSW 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Jaffe","sequence":"additional","affiliation":[{"name":"University of New South Wales; School of Women's and Children's Health; Level 8, Centre for Child Health Research & Innovation Bright Alliance Building Cnr Avoca & High Streets Randwick Sydney NSW Australia 2031"},{"name":"Sydney Children's Hospital; Respiratory Department; High Street Randwick Sydney New South Wales Australia NSW 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Y","family":"Ooi","sequence":"additional","affiliation":[{"name":"University of New South Wales; School of Women's and Children's Health; Level 8, Centre for Child Health Research & Innovation Bright Alliance Building Cnr Avoca & High Streets Randwick Sydney NSW Australia 2031"},{"name":"Sydney Children's Hospital; Gastroenterology Department; High Street Randwick Sydney NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD012949.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clnu.2007.01.004","article-title":"Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study","volume":"26","author":"Bruzzese","year":"2007","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0002|cit2","first-page":"130","article-title":"Probiotics in cystic fibrosis: help from old friends","volume":"43 Suppl 31","author":"Guarino","year":"2008","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD012949.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e87796","DOI":"10.1371\/journal.pone.0087796","article-title":"Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial","volume":"9","author":"Bruzzese","year":"2014","journal-title":"PloS one"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0004|cit4","unstructured":"EUCTR2009-011289-27-IT Probiotics in Cystic Fibrosis - ND apps.who.int\/trialsearch\/Trial3.aspx?trialid=EUCTR2009-011289-27-IT"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0005|cit5","unstructured":"NCT01961661 Probiotics on intestinal inflammation in cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT01961661"},{"issue":"3","key":"10.1002\/14651858.CD012949.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jcf.2017.10.014","article-title":"Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: a randomised placebo controlled trial","volume":"17","author":"Bruzzese","year":"2018","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0007|cit7","unstructured":"NCT01956916 Probiotics in cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT01956916"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41430-017-0043-4","article-title":"Effect of synbiotic supplementation in children and adolescents with cystic fibrosis: a randomized controlled clinical trial","volume":"72","author":"Freitas","year":"2018","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0009|cit9","first-page":"S789","article-title":"Improvement of intestinal comfort in cystic fibrosis patients after probiotics consumption","volume":"8 Suppl 2","author":"Campo","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1569-1993(13)60018-1","article-title":"Probiotic intake improves the gastrointestinal health of cystic fibrosis patients","volume":"12 Suppl 1","author":"Garriga","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","article-title":"Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study","volume":"13","author":"Campo","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00005176-199805000-00033","article-title":"Lactobacillus casei strain GG as adjunctive treatment to children with cystic fibrosis","volume":"26","author":"Benedetto","year":"1998","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD012949.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPG.0000000000000187","article-title":"Lactobacillus reuteri ATCC55730 in cystic fibrosis","volume":"58","author":"Nardo","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0014|cit14","unstructured":"NCT01737983 Effect of Lactobacillus reuteri in cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT01737983"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0015|cit15","first-page":"475","article-title":"The effect of probiotics on fecal calprotectin in patients with cystic fibrosis","volume":"55","author":"Fallahi","year":"2013","journal-title":"Turkish Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012949.pub2-BIB0016|cit16","first-page":"333","article-title":"Probiotics on fecal calprotectin of cystic fibrosis. Reply","volume":"56","author":"Yousefi","year":"2014","journal-title":"Turkish Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0017|cit17","first-page":"669","article-title":"Effects of probiotics on quality of life in children with cystic fibrosis; a randomized controlled trial","volume":"23","author":"Jafari","year":"2013","journal-title":"Iranian Journal of Pediatrics"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0018|cit18","unstructured":"NCT01201434 Effect of probiotics on sputum inflammation and pulmonary infections in patients with cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT01201434"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clnesp.2018.06.008","article-title":"Probiotics in cystic fibrosis (CF) patients: a double blind cross-over placebo controlled study. Pilot study from the ESPGHAN Working Group on Pancreas\/CF","volume":"27","author":"Biervliet","year":"2018","journal-title":"Clinical Nutrition ESPEN"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S1569-1993(17)30296-5","article-title":"Probiotics in cystic fibrosis (CF) patients: a double blind cross-over study","volume":"16 Suppl 1","author":"Biervliet","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"7","key":"10.1002\/14651858.CD012949.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0022|cit22","unstructured":"IRCT201201258778N3 Effect of probiotics on intestinal inflammation in CF patients whit age more than 4 years https:\/\/en.irct.ir\/trial\/9275"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0023|cit23","unstructured":"IRCT201205219823N1 Probiotic effect on growth and quality of life in children with cystic fibrosis www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT201205219823N1"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0024|cit24","unstructured":"ACTRN12616000797471 Probiotics and the EARly Life effects on intestinal bacteria and inflammation in children with Cystic Fibrosis (\u201cPEARL-CF\u201d) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=370881"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0025|cit25","unstructured":"IRCT2017011732004N1 Effect of synbiotic supplementation in comparison with placebo on anthropometric indices, quality of life and clinical outcome in children with cystic fibrosis en.irct.ir\/trial\/25032"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0026|cit26","unstructured":"NCT01837355 Modulation of intestinal and pulmonary inflammation by lactobacillus diet supplementation in pediatric cystic fibrosis (MoHuM-1) clinicaltrials.gov\/ct2\/show\/NCT01837355"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0027|cit27","unstructured":"RBR-5byrsc Universidade Federal de Santa Catarina - Florian\u00f3polis S. C. Brazil Universidade Federal de Santa Catarina - Florian\u00f3polis S. C. Brazil Universidade Federal de Santa Catarina - Florian\u00f3polis S. C. Brazil Effect of supplementation with a synbiotic on markers of the inflammatory response in children and adolescents with cystic fibrosis apps.who.int\/trialsearch\/Trial2.aspx?TrialID=RBR-5byrsc"},{"issue":"10","key":"10.1002\/14651858.CD012949.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00431-016-2769-8","article-title":"Probiotic supplementation in children with cystic fibrosis-a systematic review","volume":"175","author":"Ananthan","year":"2016","journal-title":"European Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012949.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcf.2016.09.004","article-title":"Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: a systematic review","volume":"16","author":"Anderson","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"16","key":"10.1002\/14651858.CD012949.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"pii: e00274-19","DOI":"10.1128\/JB.00274-19","article-title":"Altered stool microbiota of infants with cystic fibrosis shows a reduction in genera associated with immune programming from birth","volume":"201","author":"Antosca","year":"2019","journal-title":"Journal of Bacteriology"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fimmu.2014.00427","article-title":"The intestinal microbiome in early life: health and disease","volume":"5","author":"Arrieta","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1002\/14651858.CD012949.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The altered gut microbiota in adults with cystic fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiology"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0033|cit33","unstructured":"CF Foundation About cystic fibrosis www.cff.org\/What-is-CF\/About-Cystic-Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0035|cit35","unstructured":"Veritas Health Innovation Covidence"},{"issue":"8","key":"10.1002\/14651858.CD012949.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/PSY.0000000000000495","article-title":"Gut microbiota and the gut-brain axis: new insights in the pathophysiology of metabolic syndrome","volume":"79","author":"Clercq","year":"2017","journal-title":"Psychosomatic Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e0198457","DOI":"10.1371\/journal.pone.0198457","article-title":"Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis","volume":"13","author":"Freitas","year":"2018","journal-title":"PloS One"},{"issue":"2","key":"10.1002\/14651858.CD012949.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jcf.2015.08.003","article-title":"Faecal proteomics: a tool to investigate dysbiosis and inflammation in patients with cystic fibrosis","volume":"15","author":"Debyser","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0039|cit39","unstructured":"Deeks JJ Higgins JP Altman DG editor(s) on behalf of the CSMG Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/apt.14203","article-title":"Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease","volume":"46","author":"Derwa","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"22","key":"10.1002\/14651858.CD012949.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1128\/AEM.05933-11","article-title":"Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings","volume":"77","author":"Duytschaever","year":"2011","journal-title":"Applied and Environmental Microbiology"},{"issue":"6141","key":"10.1002\/14651858.CD012949.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1237439","DOI":"10.1126\/science.1237439","article-title":"The long-term stability of the human gut microbiota","volume":"341","author":"Faith","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0044|cit44","unstructured":"Food Agriculture Organization of the United Nations World Health Organization Guidelines for the evaluation of probiotics in food: report of a joint FAO\/WHO Working Group on drafting guidelines for the evaluation of probiotics in food. 2002 http:\/\/www.who.int\/foodsafety\/fs_management\/en\/probiotic_guidelines.pdf"},{"issue":"2","key":"10.1002\/14651858.CD012949.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation Consensus Report","volume":"153","author":"Farrell","year":"2008","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012949.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/s41598-017-06880-y","article-title":"A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis","volume":"7","author":"Fouhy","year":"2017","journal-title":"Scientific Reports"},{"issue":"10","key":"10.1002\/14651858.CD012949.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jcf.2017.03.010","article-title":"Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children","volume":"16","author":"Garg","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD012949.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcf.2017.07.011","article-title":"Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old","volume":"17","author":"Garg","year":"2018","journal-title":"Journal of Cystic Fibrosis"},{"issue":"8","key":"10.1002\/14651858.CD012949.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nature reviews. Gastroenterology & hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006095.pub3","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","author":"Goldenberg","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012949.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004827.pub4","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","author":"Goldenberg","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012949.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006895.pub3","article-title":"Probiotics for preventing acute upper respiratory tract infections","author":"Hao","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD012949.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0055|cit55","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0056|cit56","unstructured":"Higgins JP Altman DG Sterne JA editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0057|cit57","unstructured":"Higgins JP Deeks JJ Altman DG editor(s) on behalf of the CSMG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012949.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3945\/ajcn.110.004119","article-title":"Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program","volume":"93","author":"Jadin","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD012949.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/ped.13063","article-title":"Is there a role for stool metabolomics in cystic fibrosis?","volume":"58","author":"Kaakoush","year":"2016","journal-title":"Pediatrics International : Official Journal of the Japan Pediatric Society"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"948367","DOI":"10.1155\/2012\/948367","article-title":"Update of faecal markers of inflammation in children with cystic fibrosis","volume":"2012","author":"Lee","year":"2012","journal-title":"Mediators of Inflammation"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clnu.2014.04.004","article-title":"The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies","volume":"33","author":"Li","year":"2014","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"e00251","DOI":"10.1128\/mBio.00251-12","article-title":"Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures","volume":"3","author":"Madan","year":"2012","journal-title":"mBio"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1513\/AnnalsATS.201503-133AW","article-title":"The gut-lung axis in respiratory disease","volume":"12 Suppl 2","author":"Marsland","year":"2015","journal-title":"Annals of the American Thoracic Society"},{"issue":"9719","key":"10.1002\/14651858.CD012949.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(09)62161-9","article-title":"Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis","volume":"375","author":"McCormick","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0066|cit66","volume-title":"The prolongation of life; optimistic studies","author":"Metchnikoff","year":"1908"},{"issue":"3","key":"10.1002\/14651858.CD012949.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MPG.0000000000002185","article-title":"A systematic review of probiotics for cystic fibrosis patients: moving forward","volume":"68","author":"Neri","year":"2019","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"24857","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12519-017-0033-6","article-title":"Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials","volume":"13","author":"Nikniaz","year":"2017","journal-title":"World Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD012949.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1007\/s10620-015-3842-2","article-title":"Fecal human beta-defensin 2 in children with cystic fibrosis: is there a diminished intestinal innate immune response?","volume":"60","author":"Ooi","year":"2015","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012949.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"17834","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/jgh.12842","article-title":"Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?","volume":"30","author":"Pang","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"pii: E555","DOI":"10.3390\/nu9060555","article-title":"Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases","volume":"9","author":"Plaza-Diaz","year":"2017","journal-title":"Nutrients"},{"issue":"9","key":"10.1002\/14651858.CD012949.pub2-BIB0074|cit74","first-page":"560","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley","year":"2013","journal-title":"Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0076|cit76","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/ppul.23544","article-title":"The CF gastrointestinal microbiome: structure and clinical impact","volume":"51 Suppl 44","author":"Rogers","year":"2016","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0078|cit78","unstructured":"Sanders ME Merenstein DJ Reid G Gibson GR Rastall RA Probiotics and prebiotics in intestinal health and disease: from biology to the clinic Nature Reviews. Gastroenterology & Hepatology 10.1038\/s41575-019-0173-3"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e61176","DOI":"10.1371\/journal.pone.0061176","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients","volume":"8","author":"Schippa","year":"2013","journal-title":"PloS one"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0080|cit80","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH on behalf of the CA and RMG and the CSMG Chapter 11: Presenting results and \u2018Summary of findings\u2019 tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012949.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.2004-2832","article-title":"Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis","volume":"117","author":"Shoff","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/adc.82.5.394","article-title":"Intestinal inflammation in cystic fibrosis","volume":"82","author":"Smyth","year":"2000","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0083|cit83","unstructured":"Sterne JA Egger M Moher D editor(s) on behalf of the CBMG Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook forSystematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0084|cit84","first-page":"407","article-title":"Probiotic use and antibiotic associated gastrointestinal symptoms in pediatric patients with cystic fibrosis","volume":"50 Suppl 41","author":"Sullivan","year":"2015","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD012949.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2018.03.011","article-title":"Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis","volume":"17","author":"Sutherland","year":"2018","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD012949.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"e0174463","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS ONE"},{"issue":"40","key":"10.1002\/14651858.CD012949.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"E5934","DOI":"10.1073\/pnas.1612559113","article-title":"High-fat diet modifies the PPAR-gamma pathway leading to disruption of microbial and physiological ecosystem in murine small intestine","volume":"113","author":"Tomas","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1002\/14651858.CD012949.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD012949.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clnesp.2017.01.007","article-title":"Clinical effects of probiotics in cystic fibrosis patients: a systematic review","volume":"18","author":"Biervliet","year":"2017","journal-title":"Clinical Nutrition ESPEN"},{"issue":"12","key":"10.1002\/14651858.CD012949.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"e0208171","DOI":"10.1371\/journal.pone.0208171","article-title":"Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype","volume":"13","author":"Vernocchi","year":"2018","journal-title":"PloS One"},{"issue":"4","key":"10.1002\/14651858.CD012949.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","author":"Roon","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012949.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of intestinal inflammation in patients with cystic fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"7402","key":"10.1002\/14651858.CD012949.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012949.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T06:53:35Z","timestamp":1665557615000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012949.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":93,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012949.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]}}}